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ABSTRACT
Increased numbers of faecal Enterobacteriaceae are observed among patients with irritable bowel
syndrome. Escherichia coli strains are present in the lower intestine of humans, and may include several
potentially pathogenic adhesive pathotypes. The aim of this study was to determine whether there were
differences between the adhesive pathotypes of E. coli strains recovered from stool specimens of patients
with irritable bowel syndrome and those recovered from healthy controls. The ability of E. coli isolates to
adhere to cultured epithelial cells was assessed in an in-vitro adherence assay with HEp-2 cells.
Enteroaggregative E. coli (EAEC) strains were isolated signiﬁcantly more frequently (p <0.00001) from
patients with irritable bowel syndrome (81.8%) than from healthy controls (32.3%). However, despite
this association, the precise role of the EAEC pathotype in irritable bowel syndrome remains to be
determined.
Keywords Adhesion, EAEC, enteroaggregative Escherichia coli, irritable bowel syndrome, pathogenicity, patho-
types
Original Submission: 24 July 2006; Revised Submission: 1 October 2006; Accepted: 13 October 2006
Clin Microbiol Infect 2007; 13: 404–407
INTRODUCTION
Irritable bowel syndrome (IBS) is a common
functional intestinal disorder associated with an
altered bowel habit, including abnormal motility
and defaecation associated with pain, but with no
discernible underlying structural abnormality.
A diagnosis of IBS is made on the basis of clinical
symptoms, but because the symptoms mimic
those of many other diseases, standard diagnostic
Rome criteria have been created to identify
patients with IBS correctly [1]. The evidence
indicates that mucosal inﬂammation may play a
role in altering the gastrointestinal physiology,
and in the pathogenesis of the syndrome, in a
subset of patients with IBS. There are many
hypotheses regarding development of the mucos-
al inﬂammation associated with IBS, including
changes in gut microﬂora, previous episodes of
infectious enteritis, food allergies or genetic fac-
tors [1,2]. Although the possibility of infectious
events in the gut has been considered, the
putative pathogens that may be responsible for
altering the immunological balance of the diges-
tive tract are unknown. Garcia-Rodrigez and
Ruigomez [3] showed in a cohort study that
Salmonella or Campylobacter infection may predis-
pose a subset of individuals to IBS. An increased
number of faecal enterobacteria, and bacterial
overgrowth, has been observed among a signiﬁ-
cant subset of patients with IBS [1,4], although the
reasons for this phenomenon have not been
elucidated.
Commensal strains of Escherichia coli are present
in the lower intestine of humans. Within the
species E. coli, there are pathogenic subgroups that
are capable of causing enteric disease. A subset of
these E. coli strains belongs to adhesive pathotypes
and, according to in-vitro adherence studies, can
be divided into diffusely-adhering E. coli strains,
locally-adhering E. coli strains, and enteroaggre-
gative E. coli (EAEC) isolates that adhere in an
aggregative pattern [5]. The aim of the present
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study was to determine whether there are differ-
ences between the adhesive properties of E. coli
strains isolated from patients with IBS and those
isolated from healthy controls.
MATERIALS AND METHODS
Bacterial strains
E. coli strains were isolated from the stool specimens of 44 IBS
patients who fulﬁlled the Rome II criteria, i.e., at least 12 weeks
(which not need be consecutive) in the preceding 12 months
with abdominal discomfort or pain, together with two of the
following three features: relief following defaecation; onset
associated with a change in stool frequency; and a change in
the stool form. One stool sample was examined from each
patient. The patients (24 males, 13 females, mean age 43 years)
were diagnosed at the Department and Clinic of Gastroenter-
ology, University of Medicine, Wrocław, Poland. The predom-
inant feature of the disease in the patients examined was
diarrhoea of an intermittent course lasting for 12–24 months
(mean duration 14 months). Thirty-four stool samples ob-
tained from 34 healthy volunteers (age-matched), none of
whom had symptoms or criteria for IBS, were included as
controls.
None of the subjects included in the study had been treated
with antibiotics in the 4-week period before the collection of
samples, and all stool specimens were negative for conven-
tional bacterial pathogens (Salmonella spp., Shigella spp.,
Campylobacter spp., Yersinia spp.) and parasites. No tests were
performed for viral enteric pathogens. None of the subjects
allocated to the study had travelled to developing countries
before the samples were obtained. The stool samples were
negative for faecal occult blood. Each stool sample was
inoculated on a MacConkey agar plate and incubated at 37C
for 18 h. From each sample, ﬁve to eight bacterial colonies
were picked randomly and identiﬁed as E. coli by standard
biochemical methods. In total, 274 E. coli isolates from 44 IBS
patients (on average, six isolates from one sample) and 180
E. coli isolates from 34 healthy controls (on average, ﬁve
isolates from one sample) were examined further.
Adherence assay
Adherence to HEp-2 cells and to intestinal cell lines (Intestine
407 and Caco-2) was measured as described by Cravioto et al.
[6]. In brief, a chamber slide was seeded with cells that had
been grown to a near conﬂuent monolayer at 37C in a CO2 5%
v ⁄v atmosphere in minimal essential medium supplemented
with fetal bovine serum 10% v ⁄v (or 20% v ⁄v for Caco-2 cells)
and an antibiotic–antimycotic solution (penicillin 100 U ⁄L,
streptomycin 100 U ⁄L, amphotericin B 0.25 mg ⁄L). Before the
test was performed, the cells were washed with phosphate-
buffered saline (pH 7.2), and the cell culture medium in the
chamber slides was replaced with 0.5 mL of minimum
essential medium supplemented with fetal bovine serum 2%
v ⁄v and methyl a-D-mannopyranoside 1% w ⁄v without
antibiotics. The bacterial strains to be tested were ﬁrst grown
overnight at 37C in trypticase-soy broth, and 25 lL of
bacterial culture was then added to each chamber and
incubated for 3 or 6 h at 37C in a CO2 5% v ⁄v atmosphere.
The slides were then washed three times with phosphate-
buffered saline, ﬁxed with methanol 70% v ⁄v, and stained
with Giemsa 10% v ⁄v. The assay was repeated two or three
times for each strain.
PCR assay
Plasmid DNA was extracted from E. coli strains with Plasmid
Midi isolation kits (A & A Biotechnology, Gdynia, Poland),
used according to the manufacturer’s instructions. PCR was
performed with primers speciﬁc for the EAEC probe pCVD432
[7] in a DNA-Engine PT200 thermal cycler (MJ Research,
Waltham, MA, USA). DNA from EAEC 17-2 (O3:H2) and
laboratory E. coli K12 reference strains was included as
positive and negative controls for each assay.
Statistical analysis
The signiﬁcance of differences observed in the prevalence of
adhesion patterns was assessed using Pearson’s chi-square
test, with p £0.05 considered to be statistically signiﬁcant.
RESULTS
Several different adherence patterns were ob-
served among the 454 E. coli strains obtained from
IBS patients and controls examined in the in-vitro
adherence assay, i.e., aggregative adherence, in
which characteristic E. coli aggregates presenting
a ‘stacked-brick’ appearance adhered to HEp-2
cells and to a glass substratum, diffuse adherence
of individual bacteria to epithelial cells, and an
undeﬁned adhesive type with clusters as well as
individual bacteria adhering to HEp-2 cells. In
addition, a subset of E. coli isolates from
patients with IBS and from healthy controls was
non-adherent to epithelial cells in the presence of
D-mannose, and some E. coli strains tested be-
longed to the cell-detaching group of E. coli. In
most cases, there were isolates of different adher-
ence types among the E. coli strains from each
individual subject. The frequency of isolation of
adhesive types of E. coli from IBS patients and
from controls is summarised in Table 1.
The aggregative adherence pattern was preval-
ent among E. coli isolates from the IBS patients,
with 36 (81.8%) showing the presence of EAEC in
stool specimens, compared with 11 (32.3%)
healthy controls (p <0.00001). Moreover, EAEC
strains were isolated as the only adhesive E. coli
type from nine (20.4%) of 44 IBS patients, com-
pared with none of the controls (p 0.0003). PCR
using primers speciﬁc for the EAEC probe
pCVD432 conﬁrmed the EAEC pathotype for 33
(91.7%) of the 36 EAEC-positive IBS cases and
100% of the 11 EAEC-positive controls. Since
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some EAEC strains are cyto-detaching, all cell-
detaching E. coli isolates in the study were also
examined using the primers speciﬁc for the
pCVD432 probe. Positive PCR results were
obtained for two of 18 cell-detaching E. coli
isolates from IBS cases, and these were also
classiﬁed as EAEC; all other cyto-detaching iso-
lates tested were negative (Table 2). There were
no differences in the frequency of isolation of
diffusely adherent and non-adherent E. coli
among IBS patients and controls (p 0.08 and
p 0.4, respectively). However, E. coli strains
showing an undeﬁned adherence pattern were
isolated more frequently from IBS patients
(p <0.00001), while cell-detaching E. coli strains
were isolated more frequently from controls
(p 0.0002).
In the in-vitro adherence assay with the Caco-2
and Intestin407 human intestinal cell lines, most
of the EAEC strains examined (76.5% from cases
and 63.6% from controls) showed an aggregative
adherence pattern; only a minority of the EAEC
strains showed an undeﬁned adherence pattern
or were non-adherent (only isolates from con-
trols).
DISCUSSION
Infection and inﬂammation are thought to be
potentially involved in the pathogenicity of IBS
[8], and several microorganisms, e.g., Salmonella,
Shigella and Campylobacter, have been consid-
ered as possible factors that may trigger IBS
[3,9,10]. Although there is evidence indicating a
signiﬁcant increase in colonic E. coli among IBS
patients [11], to the best of our knowledge there
are no previous studies concerning the patho-
genic potential of E. coli strains in IBS. Since
different adherence pathotypes may exist among
pathogenic E. coli strains, the present study ana-
lysed the in-vitro line adhesive properties on
HEp-2 cells of E. coli strains isolated from stool
specimens of patients with the diarrhoeal form of
IBS. Surprisingly, EAEC strains were isolated
from 36 (81.8%) of 44 IBS cases, and most of the
isolates showed an aggregative adherence pattern
with human intestinal epithelial cells in vitro.
EAEC strains belong to the group of pathogenic
E. coli, and several case-control and cohort studies
suggest that they are an important cause of
chronic and acute diarrhoea in humans of all
ages in both developing and developed countries
[12–14]. EAEC strains have also been identiﬁed as
aetiological agents of persistent diarrhoea in
patients infected with human immunodeﬁciency
virus and those with travellers’ diarrhoea [15,16].
Moreover, according to Okhuysen et al. [17], as
many as 11% of travellers to Mexico who devel-
oped chronic diarrhoea caused by EAEC or
enterotoxigenic E. coli met the criteria for IBS for
a further 6 months.
Although the results presented in this study do
not indicate any causative correlation between
EAEC and IBS, the high frequency of isolation of
these pathogens from IBS patients seems very
intriguing, taking into consideration the bacterial
overgrowth in the intestine of IBS patients and
the common presence of mucus in the faecal
Table 1. Isolation of Escherichia coli strains of speciﬁc adherence types from patients with irritable bowel syndrome (IBS)
and controls
Patient group
(n isolates)
Adherence pattern (%)
LAL DA AA UD NA CD
IBS (274) 2 (0.7) 36 (13.1) 102 (37.2) 36 (13.1) 80 (29.2) 18 (6.7)
Controls (180) 0 52 (28.9) 26 (14.4) 12 (6.7) 83 (46.1) 7 (3.9)
LAL, localised adherence; DA, diffuse adherence; AA, aggregative adherence; UD, undeﬁned adherence; NA, non-adherence; CD, cell detachment.
Table 2. Association between patients with irritable bowel syndrome (IBS) and the isolation of Escherichia coli strains
belonging to different adherence types
Patient group
(n patients)
Adherence pattern (%)
LAL DA AA UD NA CD
IBS (44) 2 (4.5) 18 (40.9) 36 (81.8) 13 (29.5) 24 (54.5) 7.(15.9)
Controls (34) 0 11 (32.3) 11 (32.3) 3 (8.8) 21 (61.8) 7.(20.6)
LAL, localised adherence; DA, diffuse adherence; AA, aggregative adherence; UD, undeﬁned adherence; NA, non-adherence; CD, cell-detachment.
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specimens of these patients, particularly when
coupled with the predilection of EAEC strains for
causing persistent infection and their ability to
form a mucous bioﬁlm on the intestinal mucosa of
infected individuals, which might explain the
bacterial overgrowth. It can be speculated that a
persisting increase in rectal mucosal enteroendo-
crine cells, revealed in patients with IBS [9], might
be associated with elevated levels of endocrine
hormones being released into the intestinal envi-
ronment, which, in turn, has been shown to
modulate the growth of microoroganisms, result-
ing in bacterial abundance [18]. Similarly, despite
normal-looking mucosa in most patients with IBS,
or only minor changes during the acute illness, a
persisting increase in intestinal mucosal
T-lymphocytes, compared with healthy individu-
als, can lead to disruption of the intestinal mucosa
and enhanced expression on the surface of epi-
thelial cells of receptors speciﬁc for bacterial
adhesins, thereby increasing their adherence and
the abundance of these organisms in the intestine
of IBS patients [9,10]. Nevertheless, it cannot be
excluded that persistent EAEC infection may
trigger IBS, e.g., in genetically predisposed indi-
viduals, since other studies have shown that
EAEC strains are able to elicit mucosal inﬂam-
mation, and concentrations of interleukin-1b,
interleukin-8 and lactoferrin are elevated in the
stool specimens of individuals infected with
EAEC, regardless of the presence of symptoms
[19–21]. Therefore, the precise role of the EAEC
pathotype in IBS remains to be determined.
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